$14.98
-0.30[-1.96%]
At close: Apr 23
$14.98
0[0.00%]
After Hours: 6:21PM EDT
Immunome reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immunome using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | IMNM | Q1 | -$0.35 | -$1.23 | — | — | $2.36M | $4.10M | — | — | Get Alert |
03/28/2024 | PM | IMNM | Q4 | -$0.64 | -$0.28 | -$0.15 | 46.43% | $0.00 | $2.07M | $3.83M | 84.83% | Get Alert |
11/09/2023 | AM | IMNM | Q3 | -$0.75 | — | -$0.36 | — | $0.00 | — | $3.56M | — | Get Alert |
08/09/2023 | AM | IMNM | Q2 | -$0.74 | -$0.16 | -$0.46 | -187.50% | $0.00 | — | $4.26M | — | Get Alert |
05/05/2023 | AM | IMNM | Q1 | -$0.96 | $0.58 | -$0.35 | -160.34% | $0.00 | — | $2.36M | — | Get Alert |
03/16/2023 | AM | IMNM | Q4 | -$0.65 | -$0.67 | -$0.64 | 4.48% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2022 | AM | IMNM | Q3 | -$0.65 | -$0.76 | -$0.75 | 1.32% | $0.00 | — | $0.00 | — | Get Alert |
08/05/2022 | AM | IMNM | Q2 | -$0.46 | -$0.75 | -$0.74 | 1.33% | $0.00 | — | $0.00 | — | Get Alert |
05/12/2022 | AM | IMNM | Q1 | -$0.37 | -$0.69 | -$0.96 | -39.13% | $0.00 | — | $0.00 | — | Get Alert |
03/28/2022 | AM | IMNM | Q4 | -$0.40 | -$0.81 | -$0.65 | 19.75% | $0.00 | — | $0.00 | — | Get Alert |
11/15/2021 | PM | IMNM | Q3 | -$7.52 | -$0.81 | -$0.65 | 19.75% | $0.00 | — | $0.00 | — | Get Alert |
08/16/2021 | PM | IMNM | Q2 | — | -$0.39 | -$0.46 | -17.95% | — | $3.80M | $0.00 | -100.00% | Get Alert |
05/12/2021 | AM | IMNM | Q1 | -$2.44 | -$0.39 | -$0.37 | 5.13% | — | $3.80M | $0.00 | -100.00% | Get Alert |
03/25/2021 | PM | IMNM | Q4 | — | — | -$0.40 | — | — | — | $0.00 | — | Get Alert |
11/17/2020 | PM | IMNM | Q3 | -$2.50 | — | -$7.52 | — | — | — | $0.00 | — | Get Alert |
Immunome (IMNM) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.15, which beat the estimate of $-0.28.
The Actual Revenue was $3.8M, which beat the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.